Delivery Order SPE2DB22D3016-SPE2DB25FBAY3
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a ceiling value of $3,210.88. The contract is a Firm Fixed Price Delivery Order with a completion date of July 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,605.44 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, with a completion date of July 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is for the delivery of RYANODEX 250MG VIAL 1S, a medical supply product, with a ceiling value of $4,816.32 and a performance period ending on July 17, 2025. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a ceiling value of $24,081.60 and a performance period ending on July 21, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RYANODEX 250 MG VIALS. The contract is a firm fixed-price delivery order with a ceiling value of $1,605.44 and a period of performance through June 3, 2025. This contract is not set aside and is awarded as open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,566.40 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, with an ultimate completion date of October 21, 2022. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the Medical Supply Chain division of the Defense agency. The award, valued at $4,468.92, was issued to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of June 17, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $3,210.88 and a performance period through July 9, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a...
- This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and the pharmaceutical distributor Amerisourcebergen Drug Corp. The $8,937.84 firm fixed-price delivery order is for the supply of RYANODEX 250MG VIAL 1S, a specialty pharmaceutical product. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a ceiling value of $1,605.44. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBAY3Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, with a ceiling value of $16,054.40. The contract is a firm-fixed-price Delivery Order, with a period of performance ending on July 24, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and no subcontractors are mentioned. As a major pharmaceutical distributor, the company is a critical vendor in supporting the federal government's medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 7/2/25 |